Literature DB >> 8407550

Effects of chronic administration of low doses of 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline on glutathione S-transferase placental form-positive foci development in the livers of rats fed a choline-deficient diet.

H Sone1, K Wakabayashi, H Kushida, M Ochiai, T Sugimura, M Nagao.   

Abstract

Effects of chronic administration of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) at the very low doses of 0.4 and 4 ppm, respectively 1000- and 100-fold less than the dose shown to be carcinogenic (400 ppm), on the liver of rats fed a choline-deficient (CD) diet were examined in terms of glutathione S-transferase placental form (GST-P)-positive foci. Male F344 rats were given CD diet containing 0, 0.4 or 4 ppm MeIQx for 20 or 40 weeks. As controls, rats received choline-supplemented (CS) diet in the same manner. MeIQx at 4 ppm in the CD diet significantly increased both the number and area of GST-P-positive foci, the values being 2.3- and 2.1-fold at 20 weeks and 2.0- and 3.3-fold at 40 weeks, respectively, compared with those observed for CD diet alone. MeIQx at 0.4 ppm in CD diet did not affect the development of GST-P-positive foci. No influence of the heterocyclic amine was found in the CS groups, where only very small numbers of minute lesions were observed. The level of MeIQx-DNA adducts in rats given the CD diet containing 4 ppm MeIQx was 2- to 3-fold lower than that in rats given the CS diet containing 4 ppm MeIQx at 20 and 40 weeks. This result indicates that DNA adduct formation and cell proliferation are both required for the increase of GST-P-positive foci in rats fed 4 ppm MeIQx in a CD diet. The above findings strongly suggest that MeIQx could be carcinogenic even at 4 ppm under CD conditions, where liver cell regeneration is continuously occurring.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407550      PMCID: PMC5919264          DOI: 10.1111/j.1349-7006.1993.tb02058.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  25 in total

1.  Mutagen activation by cDNA-expressed P(1)450, P(3)450, and P450a.

Authors:  T Aoyama; F J Gonzalez; H V Gelboin
Journal:  Mol Carcinog       Date:  1989       Impact factor: 4.784

2.  Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.

Authors:  T Kato; H Ohgaki; H Hasegawa; S Sato; S Takayama; T Sugimura
Journal:  Carcinogenesis       Date:  1988-01       Impact factor: 4.944

3.  Mutagenic and carcinogenic heterocyclic amines in Chinese cooked foods.

Authors:  X M Zhang; K Wakabayashi; Z C Liu; T Sugimura; M Nagao
Journal:  Mutat Res       Date:  1988-09       Impact factor: 2.433

4.  Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process.

Authors:  T Sugimura
Journal:  Mutat Res       Date:  1985 Jun-Jul       Impact factor: 2.433

5.  Increased cell division as a cause of human cancer.

Authors:  S Preston-Martin; M C Pike; R K Ross; P A Jones; B E Henderson
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

6.  Comparison of initiation potential of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in an in vivo carcinogen bioassay system.

Authors:  H Tsuda; S Takahashi; S Yamaguchi; K Ozaki; N Ito
Journal:  Carcinogenesis       Date:  1990-04       Impact factor: 4.944

7.  Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA.

Authors:  K W Turteltaub; J S Felton; B L Gledhill; J S Vogel; J R Southon; M W Caffee; R C Finkel; D E Nelson; I D Proctor; J C Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

8.  Effects of a choline-deficient diet and a hypolipidemic agent on single glutathione S-transferase placental form-positive hepatocytes in rat liver.

Authors:  K Yokota; U Singh; H Shinozuka
Journal:  Jpn J Cancer Res       Date:  1990-02

9.  DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration.

Authors:  K Yamashita; M Adachi; S Kato; H Nakagama; M Ochiai; K Wakabayashi; S Sato; M Nagao; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1990-05

10.  Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Authors:  H Esumi; H Ohgaki; E Kohzen; S Takayama; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1989-12
View more
  4 in total

Review 1.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

2.  Hepatocellular carcinoma induction in LEC rats by a low dose of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.

Authors:  H Sone; K Wakabayashi; H Kushida; K Enomoto; M Mori; N Takeichi; H Tsuda; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1996-01

3.  Formation and removal of DNA adducts in the liver of rats chronically fed the food-borne carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.

Authors:  M Hirose; K Wakabayashi; M Ochiai; H Kushida; H Sato; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1995-06

4.  Dose-dependent induction of 8-hydroxyguanine and preneoplastic foci in rat liver by a food-derived carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, at low dose levels.

Authors:  T Kato; R Hasegawa; D Nakae; M Hirose; M Yaono; L Cui; Y Kobayashi; Y Konishi; N Ito; T Shirai
Journal:  Jpn J Cancer Res       Date:  1996-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.